Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Phase-1 Study of Vamotinib (PF-114), a 3rd Generation BCR::ABL1 Tyrosine Kinase-Inhibitor, in Chronic Myeloid Leukaemia

Anna Turkina,Olga Vinogradova,Elza Lomaia,Evgeniya Shatokhina,Oleg Shukhov,Ekaterina Chelysheva,Dzhariyat Shikhbabaeva,Irina Nemchenko,Anna Petrova,Anastasiya Bykova,Nadiya Siordiya,Vasily Shuvaev,Ilya Mikhailov,Fedor Novikov,Veronika Shulgina,Andreas Hochhaus,Oliver Ottmann,Jorge Cortes, Robert Peter Gale,Ghermes Chilov

Annals of Hematology（2025）

Cited 0|Views2

Key words

Chronic myeloid leukaemia,Tyrosine kinase inhibitor,PF-114,Vamotinib

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined